Your browser doesn't support javascript.
loading
Utility of F-18 Fluorodeoxyglucose Positron Emission Tomography - Computed Tomography in Primary Thyroid Lymphoma.
Singh, Vijay; Mishra, Ayush; Kalimuthu, Lokeshwaran; Ora, Manish; Nazar, Aftab Hasan; Gambhir, Sanjay.
Afiliação
  • Singh V; Department of Nuclear Medicine, SGPGIMS, Lucknow, Uttar Pradesh, India.
  • Mishra A; Department of Nuclear Medicine, SGPGIMS, Lucknow, Uttar Pradesh, India.
  • Kalimuthu L; Department of Nuclear Medicine, SGPGIMS, Lucknow, Uttar Pradesh, India.
  • Ora M; Department of Nuclear Medicine, SGPGIMS, Lucknow, Uttar Pradesh, India.
  • Nazar AH; Department of Nuclear Medicine, SGPGIMS, Lucknow, Uttar Pradesh, India.
  • Gambhir S; Department of Nuclear Medicine, SGPGIMS, Lucknow, Uttar Pradesh, India.
Indian J Nucl Med ; 37(4): 379-386, 2022.
Article em En | MEDLINE | ID: mdl-36817193
ABSTRACT
Primary thyroid lymphoma (PTL) is an uncommon malignancy. The majority of PTLs are non-Hodgkin's lymphoma. Fluorodeoxyglucose positron emission tomography-computed tomography (FDG PET/CT) is the state-of-the-art imaging in lymphoma and plays a pivotal role in staging, follow-up, and treatment decisions. There is good evidence that it performs well in a wide variety of nodal and extranodal lymphomas (ENL). However, the data are scarce on its usefulness in rare ENL. Herein, we describe four cases of PTLs and a brief review of the literature. FDG PET/CT was performed at baseline to assess the disease status and response to treatment. This case series highlights the varied appearance of PTL and response to treatment. It establishes the importance of FDG PET/CT in the personalized management of PTL.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article